Prognostic Value of Stress-Induced Hyperglycemia in High-Acuity Emergency Department Patients
Authors:
- Aikaterini ApostolopoulouAAAikaterini Apostolopoulou
- Christos KofosCKChristos Kofos
- Marios G. BantidosMarios G. Bantidos
- Sofia-Chrysovalantou ZagaliotiSZSofia-Chrysovalantou Zagalioti
- Sofia GkarmiriSGSofia Gkarmiri
- Anna DrokouADAnna Drokou
- Christina KaltsidouCKChristina Kaltsidou
- Nikolaos KoumianakisNKNikolaos Koumianakis
- Aikaterini LetsiouALAikaterini Letsiou
- Eleni PanayiEPEleni Panayi
- Grigorios VoulgarisGVGrigorios Voulgaris
- Paraskevi KatranaPKParaskevi Katrana
Open Access
- 19 February 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1618
Abstract
Background/Objectives: Stress-induced hyperglycemia (SIH) is frequently observed in critically ill patients and has been associated with adverse outcomes in individuals both with and without known diabetes mellitus (DM). However, evidence regarding its prognostic utility for in-hospital mortality in high-acuity emergency department (ED) populations remains limited. Methods: We conducted a retrospective observational cohort study of consecutive adult ED patients classified as Emergency Severity Index (ESI) triage level 1. SIH was defined a priori as an admission serum glucose > 140 mg/dL, a pragmatic cutoff widely applied in clinical practice despite ongoing debate regarding optimal pathophysiological thresholds. Associations with in-hospital mortality were assessed using logistic regression in the overall cohort and stratified by DM status. Additional analyses assessed the prognostic performance of admission glucose as a continuous variable. Results: Of 470 included patients, 435 had complete mortality data; 247 (56.8%) died during hospitalization. SIH was present in 258/435 (59.3%)and known DM in 114/435 (26.2%). SIH was associated with higher in-hospital mortality in univariate analysis (OR 2.90, 95% CI 1.91–4.43; p < 0.001) and remained independently associated after adjustment (adjusted OR 2.22, 95% CI 1.41–3.51; p < 0.001). The association between SIH and mortality persisted in both non-DM and DM subgroups, with no significant interaction by DM status. SIH alone showed modest discrimination for mortality (AUC 0.625, 95% CI 0.572–0.669), whereas continuous admission glucose performed better. Discrimination improved in the multivariable model (AUC 0.728, 95% CI 0.677–0.779). Restricted cubic spline analysis demonstrated a strong overall association between admission glucose and mortality without evidence of nonlinearity, indicating an approximately linear risk increase across the observed glucose range. Conclusions: Regarding severely ill ED patients, classified as ESI triage 1, SIH is an independent predictor of in-hospital mortality irrespective of DM status. Admission glucose may improve early risk stratification when incorporated into clinical models.Keywords
This publication has 34 references indexed in Scilit:
- Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortalityIntensive Care Medicine, 2014
- Stress-Induced Hyperglycemia, Not Diabetic Hyperglycemia, Is Associated With Higher Mortality in TraumaAnnals of Surgery, 2012
- Elevated Admission Glucose and Mortality in Patients With Acute Pulmonary EmbolismDiabetes Care, 2011
- Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*Critical Care Medicine, 2009
- Hyperglycemia as a Predictor of In‐Hospital Mortality in Elderly Patients without Diabetes Mellitus Admitted to a Sub‐Intensive Care UnitJournal of the American Geriatrics Society, 2008
- Admission glycaemia and outcome after acute coronary syndromeInternational Journal of Cardiology, 2007
- Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated PatientsStroke, 2003
- Adrenal Insufficiency in the Critically IllChest, 2002
- The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 1999
- Sepsis and serum cytokine concentrationsCritical Care Medicine, 1997